Body Dysmorphic Disorder in Oculofacial Surgery
All content on Eyewiki is protected by copyright law and the Terms of Service. This content may not be reproduced, copied, or put into any artificial intelligence program, including large language and generative AI models, without permission from the Academy.
Body dysmorphic disorder (BDD) is an excessive preoccupation with minimal or unnoticeable appearance flaws. In the setting of oculoplastics, patients often fixate on eyelid asymmetry, ptosis, or periorbital fullness that doesn't match objective exam findings. Rates are far higher in cosmetic settings (up to 20% in some clinics) than in the general population (about 2%). Diagnosis hinges on recognizing the mismatch between subjective complaint and exam or photographic findings; however, validated tools like the BDDQ or DCQ are helpful since surgeons correctly identify only a small fraction of cases on their own. First line treatment is SSRIs and CBT. Surgery rarely improves BDD symptoms and can in fact worsen distress. Awareness of BDD is essential to protect both patient wellbeing and the surgeon patient relationship.
Disease Entity
Disease
Body dysmorphic disorder (BDD) is a psychiatric condition defined by excessive preoccupation with one or more perceived body defects that are minimal or not observable to others.1 It is classified under obsessive compulsive disorder (OCD) and related illness in the DSM-5.2 Affected individuals engage in repetitive behaviors, such as excess grooming, mirror checking, skin picking, and comparison of themselves to others, to the point that it impairs their ability to function in their daily lives.
BDD is particularly relevant to oculoplastics as the face is highly visible and plays a key role in a patient's identity. Patients may present with concerns regarding perceived facial asymmetry, ptosis, and scar appearance. Recognition of BDD is important because surgical intervention does not improve underlying psychiatric turmoil and has been shown to actually cause increased dissatisfaction in appearance, repetitive medical evaluations, and distress.
Risk Factors
Risk factors for patients with BDD in a cosmetic surgery setting include those for BDD at large:3,4,12
- Personal or family history of obsessive-compulsive disorder, anxiety, depression, or BDD
- Perfectionism or high appearance-related concern
- History of teasing, bullying, trauma, or criticism related to appearance
- High use of mirrors, photographs, or social media filters
- Prior cosmetic procedures with persistent dissatisfaction
- Social anxiety or avoidance related to appearance
- Poor insight into the discrepancy between the perceived defect and objective findings.
It has been suspected that the use of social media may contribute to the development of BDD through exposure to idealized or digitally altered images. While no causal relationship has been found, one study found that patients with BDD tend to spend more time on social media.6,12 Moreover, the comparison of one’s body to those seen on social media has been shown to correlate with the severity of body dissatisfaction.13
Pathophysiology
The pathophysiology of BDD is incompletely understood. However, the involved neurological structures are similar to those implicated in OCD. Patients with BDD have been shown to have abnormal visual processing on fMRI, associated with lower activity in the occipital and prefrontal cortices, whereby they amplify smaller details without integrating them into a larger holistic picture. This could explain why BDD sufferers perceive the severity of their “defects” to be out of proportion to the perception of others.10,11 It also explains why surgical “correction” is often unsatisfactory to said patients since the underlying cognitive disturbance remains unresolved.
Diagnosis
History
BDD can start at any time, but most commonly arises in adolescence or early adulthood.14 A patient with BDD presenting to an oculoplastic surgeon may describe longstanding preoccupation with a specific aspect of their periocular appearance, often predating the surgical consultation by years. Common historical features include seeking repeated reassurance from family members, friends, or healthcare providers regarding the perceived defect; spending hours daily checking mirrors or reflective surfaces; and avoiding social situations, photography, or eye contact due to appearance concerns.15
A detailed surgical history is essential. Many BDD patients have undergone one or more procedures, sometimes by multiple surgeons, and remain unsatisfied even when objective findings and photographs show a technically successful outcome.16 A history of changing concerns where partial satisfaction with one surgical site is followed by emergence of a new area of preoccupation is common.17 Patients may also report a history of depression, anxiety disorders, or prior psychiatric treatment, which they may or may not disclose; major depressive disorder is present as a lifetime comorbidity in approximately 75% of BDD patients, while social anxiety disorder is found in approximately 38%.18
Physical Examination
Examination of the periorbital region should be conducted as in any oculoplastic consultation, as there could be legitimate concerns that necessitate intervention. Exams should include objective measurement of all relevant parameters. Standardized preoperative photographs are critical as they document objective data gained from the exam.
The discrepancy between the patient's reported concern and the objective examination findings is a key diagnostic sign. In BDD, the perceived defect is either absent or of such minimal degree that it would not warrant clinical attention. Asymmetry within normal biological variation may be experienced by the BDD patient as grotesque or disfiguring. Noting this discrepancy in the medical record, with photographic documentation, is essential.
Clinical Diagnosis
Body dysmorphic disorder is defined by the following core:
- Preoccupation with perceived flaws in appearance that are minimal or not apparent to others
- Repetitive behaviors or mental acts related to the appearance concern
- Clinically significant distress or functional impairment
- Symptoms not better explained by an eating disorder or weight-related concern
While the concern may be targeted towards any body part, sites typically relevant to oculoplastics include the eyelids, brow, and orbital contour.
Diagnostic Screening
Evaluation by a psychiatrist or clinical psychologist is required for a formal diagnosis of BDD. However, the oculoplastic surgeon can play a critical first-line role in identification. Several validated instruments have been developed for use in clinical settings (see Table 1).
The Body Dysmorphic Disorder Questionnaire (BDDQ) is a brief, four-item self-report screening tool validated in cosmetic surgery populations, with sensitivity of approximately 100% and specificity of 93%.18 The Cosmetic Procedure Screening Questionnaire (COPS) was specifically designed for use in cosmetic surgery clinics and assesses preoccupation severity, functional impairment, and surgical outcome expectations.19 For severity rating once diagnosis is established, the Yale-Brown Obsessive Compulsive Scale modified for BDD (BDD-YBOCS) is the clinician-administered gold standard, with a 12-item structure assessing preoccupation, distress, and functional impairment over the preceding week.20
Table 1: Validated Tests for Body Dysmorphic Disorder
| Instrument | Format | Items | Key Features |
| BDDQ | Self-report | 4 | Validated in cosmetic surgery for screening; rapid to administer |
| COPS | Self-report | 9 | Developed for cosmetic surgery clinics; assesses severity, impairment, and surgical outcome expectations |
| BDD-YBOCS | Clinician-administered | 12 | Gold standard for severity; scores ≥30 indicate severe BDD; used for monitoring treatment response |
| DCQ | Self-report | 7 | Brief and validated for BDD screening; cutoff scores vary by setting |
Management
Medical Therapy
First line management of BDD includes selective serotonin reuptake inhibitors, which have a response rate of 50-70% in randomized trials. Adjuvant therapies, such as atypical antipsychotics, can also be used. A minimum treatment time of 3-4 months is necessary to determine efficacy. 21
Medical Follow-up
Psychotherapy plays a critical role in management of BDD. Specifically, cognitive behavioral therapy (CBT) and exposure therapy are first line therapy models for both BDD and OCD. Psychotherapy has demonstrated great efficacy both in person and in virtual formats. The CBT model focuses on three areas: cognitive restructuring of appearance-related beliefs, exposure to avoided situations, and response prevention. Response prevention includes elimination of mirror checking, reassurance seeking, camouflaging, and other safety behaviors that maintain the disorder. Therapy targeted towards avoiding focus on insignificant details has been shown to normalize global visual processing in preliminary studies.18 Meta-analysis has confirmed that both CBT and SSRIs produce clinically meaningful reductions in BDD symptom severity, and combined treatment may yield superior outcomes to either modality alone.22,23
Surgery
Cosmetic surgery is not recommended in patients who present with inadequately treated BDD. Research shows cosmetic surgical procedures fail to improve BDD symptoms in the majority of cases. Among 250 persons with BDD who had received cosmetic treatment, the most common outcome was no change in BDD severity, and in a survey of 265 cosmetic surgeons, only 1% of cases resulted in BDD symptom improvement.16,24 Only 25% of patients showed longer-term improvement in their appraisal of the treated body part, and only 2.3% of procedures led to improvement in overall BDD severity.16,24 In one dedicated oculoplastics study, patients with BDD who underwent surgery were more likely to have postoperative pain and undergo additional surgery. 5
Prognosis
BDD is a chronic debilitating mental condition that negatively impacts a person's life. However, patients who undergo evidence-based psychiatric treatment can have substantial improvement in their mental state. One study notes about a 20% recovery rate within one year without treatment. However, the recovery rate of patients treated with evidence-based therapy, e.g. pharmacotherapy and/or psychotherapy, ranges from 50-80%.25 To optimize patient outcomes, oculoplastics surgeons can implement screening techniques, utilize psychiatric referrals, and assess for the role of surgery and/or adequate BDD management prior to any elective surgery.
References
1. Jassi A, Krebs G. Body Dysmorphic Disorder. Psychiatr Clin North Am. 2023;46(1):197-209. doi:10.1016/j.psc.2022.10.005
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association; 2013. doi:10.1176/appi.books.9780890425596
3. Rück C, Mataix-Cols D, Feusner JD, et al. Body dysmorphic disorder. Nat Rev Dis Primer. 2024;10(1):92. doi:10.1038/s41572-024-00577-z
4. Krebs G, Clark BR, Ford TJ, Stringaris A. Epidemiology of Body Dysmorphic Disorder and Appearance Preoccupation in Youth: Prevalence, Comorbidity and Psychosocial Impairment. J Am Acad Child Adolesc Psychiatry. 2025;64(1):30-40. doi:10.1016/j.jaac.2024.01.017
5. Woolley AJ, Perry JD. Body dysmorphic disorder: prevalence and outcomes in an oculofacial plastic surgery practice. Am J Ophthalmol. 2015;159(6):1058-1064.e1. doi:10.1016/j.ajo.2015.02.014
6. Stevens SM, Markatia ZA, Ameli K, Bayaraa E, Lee WW. Prevalence of Body Dysmorphic Disorder in Orbital Plastic Surgery and Its Relationship with the Use of Social Media. Aesthetic Plast Surg. 2023;47(6):2447-2452. doi:10.1007/s00266-023-03483-z
7. Phillips KA, Dufresne RG, Wilkel CS, Vittorio CC. Rate of body dysmorphic disorder in dermatology patients. J Am Acad Dermatol. 2000;42(3):436-441. doi:10.1016/s0190-9622(00)90215-9
8. Veale D, De Haro L, Lambrou C. Cosmetic rhinoplasty in body dysmorphic disorder. Br J Plast Surg. 2003;56(6):546-551. doi:10.1016/s0007-1226(03)00209-1
9. Joseph AW, Ishii L, Joseph SS, et al. Prevalence of Body Dysmorphic Disorder and Surgeon Diagnostic Accuracy in Facial Plastic and Oculoplastic Surgery Clinics. JAMA Facial Plast Surg. 2017;19(4):269-274. doi:10.1001/jamafacial.2016.1535
10. Feusner JD, Townsend J, Bystritsky A, Bookheimer S. Visual information processing of faces in body dysmorphic disorder. Arch Gen Psychiatry. 2007;64(12):1417-1425. doi:10.1001/archpsyc.64.12.1417
11. Feusner JD, Hembacher E, Moller H, Moody TD. Abnormalities of Object Visual Processing in Body Dysmorphic Disorder. Psychol Med. 2011;41(11):2385-2397. doi:10.1017/S0033291711000572
12. Ateq K, Alhajji M, Alhusseini N. The association between use of social media and the development of body dysmorphic disorder and attitudes toward cosmetic surgeries: a national survey. Front Public Health. 2024;12:1324092. doi:10.3389/fpubh.2024.1324092
13. Jiotsa B, Naccache B, Duval M, Rocher B, Grall-Bronnec M. Social Media Use and Body Image Disorders: Association between Frequency of Comparing One’s Own Physical Appearance to That of People Being Followed on Social Media and Body Dissatisfaction and Drive for Thinness. Int J Environ Res Public Health. 2021;18(6):2880. doi:10.3390/ijerph18062880
14. Bjornsson AS, Didie ER, Grant JE, Menard W, Stalker E, Phillips KA. Age at Onset and Clinical Correlates in Body Dysmorphic Disorder. Compr Psychiatry. 2013;54(7):893-903. doi:10.1016/j.comppsych.2013.03.019
15. Phillips KA, Stout RL. Associations in the Longitudinal Course of Body Dysmorphic Disorder with Major Depression, Obsessive Compulsive Disorder, and Social Phobia. J Psychiatr Res. 2006;40(4):360-369. doi:10.1016/j.jpsychires.2005.10.001
16. Crerand CE, Menard W, Phillips KA. Surgical and Minimally Invasive Cosmetic Procedures among Persons with Body Dysmorphic Disorder. Ann Plast Surg. 2010;65(1):11-16. doi:10.1097/SAP.0b013e3181bba08f
17. Phillips KA, Grant J, Siniscalchi J, Albertini RS. Surgical and Nonpsychiatric Medical Treatment of Patients With Body Dysmorphic Disorder. Psychosomatics. 2001;42(6):504-510. doi:10.1176/appi.psy.42.6.504
18. Dey JK, Ishii M, Phillis M, Byrne PJ, Boahene KD, Ishii LE. Body dysmorphic disorder in a facial plastic and reconstructive surgery clinic: measuring prevalence, assessing comorbidities, and validating a feasible screening instrument. JAMA Facial Plast Surg. 2015;17(2):137-143. doi:10.1001/jamafacial.2014.1492
19. Veale D, Ellison N, Werner TG, Dodhia R, Serfaty MA, Clarke A. Development of a Cosmetic Procedure Screening Questionnaire (COPS) for Body Dysmorphic Disorder. J Plast Reconstr Aesthet Surg. 2012;65(4):530-532. doi:10.1016/j.bjps.2011.09.007
20. Phillips KA, Hollander E, Rasmussen SA, Aronowitz BR, DeCaria C, Goodman WK. A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale. Psychopharmacol Bull. 1997;33(1):17-22.
21.Phillips KA. Pharmacotherapy for Body Dysmorphic Disorder. Psychiatr Ann. 2010;40(7):325-332. doi:10.3928/00485713-20100701-05
22. Greenberg JL, Phillips KA, Steketee G, Hoeppner SS, Wilhelm S. Predictors of Response to Cognitive-Behavioral Therapy for Body Dysmorphic Disorder. Behav Ther. 2019;50(4):839-849. doi:10.1016/j.beth.2018.12.008
23. Harrison A, Fernández de la Cruz L, Enander J, Radua J, Mataix-Cols D. Cognitive-behavioral therapy for body dysmorphic disorder: A systematic review and meta-analysis of randomized controlled trials. Clin Psychol Rev. 2016;48:43-51. doi:10.1016/j.cpr.2016.05.007
24. Sarwer DB, Spitzer JC. Body image dysmorphic disorder in persons who undergo aesthetic medical treatments. Aesthet Surg J. 2012;32(8):999-1009. doi:10.1177/1090820X12462715
25. Phillips KA, Pagano ME, Menard W, Stout RL. A 12-Month Follow-Up Study of the Course of Body Dysmorphic Disorder. Am J Psychiatry. 2006;163(5):907-912. doi:10.1176/appi.ajp.163.5.907
